AR062801A2 - Peptidos liberadores de la hormona de crecimiento - Google Patents
Peptidos liberadores de la hormona de crecimientoInfo
- Publication number
- AR062801A2 AR062801A2 ARP080101348A ARP080101348A AR062801A2 AR 062801 A2 AR062801 A2 AR 062801A2 AR P080101348 A ARP080101348 A AR P080101348A AR P080101348 A ARP080101348 A AR P080101348A AR 062801 A2 AR062801 A2 AR 062801A2
- Authority
- AR
- Argentina
- Prior art keywords
- bzl
- peptides
- releasing
- 1nal
- 2nal
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- JPZXHKDZASGCLU-GFCCVEGCSA-N 3-(2-Naphthyl)-D-Alanine Chemical compound C1=CC=CC2=CC(C[C@@H](N)C(O)=O)=CC=C21 JPZXHKDZASGCLU-GFCCVEGCSA-N 0.000 abstract 2
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 abstract 2
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- HRNLPPBUBKMZMT-SSSXJSFTSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2r)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Chemical class C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](C)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(=O)[C@H](N)C)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=CC=C1 HRNLPPBUBKMZMT-SSSXJSFTSA-N 0.000 abstract 1
- ONOURAAVVKGJNM-SCZZXKLOSA-N (2s,3r)-2-azaniumyl-3-phenylmethoxybutanoate Chemical compound [O-]C(=O)[C@@H]([NH3+])[C@@H](C)OCC1=CC=CC=C1 ONOURAAVVKGJNM-SCZZXKLOSA-N 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 101100431670 Rattus norvegicus Ybx3 gene Proteins 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000816 peptidomimetic Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
Abstract
Se describen compuestos peptídicos y peptidomiméticos en general de acuerdo con la formula R1-A1-A2-A3-A4-A5-R2, y sus sales aceptables para uso farmacéutico de los mismos, que son utiles como análogos de GHRP: o una sal aceptable para uso farmacéutico del mismo, en el cual: A1 es Aib, Apc o Inp; A2 es D-Bal, D-Bip, DBpa, D-Dip, D-1Nal, D-2Nal, D-Ser(Bzl) o D-Trp; A3 es D-Bal, D-Bip, D-Bpa, D-Dip, D-1Nal, D-2Nal, D-Ser(Bzl) o D-Trp; A4 es 2Fua, Orn, 2Pal, 3Pal, 4Pal, Pff, Phe, Pim, Taz, 2Thi, 3Thi, Thr(Bzl); A5 es Apc, Dab, Dap, Lys, Orn o se suprime; R1 es hidrogeno, alquilo C1-6, arilo C5-14, alquilo-(C1-6)arilo C5-14, cicloalquilo C3-8 o acilo C2-10; y R2 es OH o NH2; y composiciones farmacéuticas y métodos de uso de las mismas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40226302P | 2002-08-09 | 2002-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062801A2 true AR062801A2 (es) | 2008-12-10 |
Family
ID=31715820
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030102883A AR040965A1 (es) | 2002-08-09 | 2003-08-08 | Peptidos liberadores de la hormona de crecimiento |
| ARP080101348A AR062801A2 (es) | 2002-08-09 | 2008-03-31 | Peptidos liberadores de la hormona de crecimiento |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030102883A AR040965A1 (es) | 2002-08-09 | 2003-08-08 | Peptidos liberadores de la hormona de crecimiento |
Country Status (22)
| Country | Link |
|---|---|
| US (7) | US7456253B2 (es) |
| EP (2) | EP1542716B1 (es) |
| JP (2) | JP4365319B2 (es) |
| KR (1) | KR100967572B1 (es) |
| CN (3) | CN101108875A (es) |
| AR (2) | AR040965A1 (es) |
| AT (1) | ATE447411T1 (es) |
| AU (1) | AU2003259062B2 (es) |
| BR (2) | BRPI0313273B8 (es) |
| CA (1) | CA2494300C (es) |
| CZ (1) | CZ20041254A3 (es) |
| DE (1) | DE60329923D1 (es) |
| DK (1) | DK1542716T3 (es) |
| ES (1) | ES2334223T3 (es) |
| IL (1) | IL165998A (es) |
| MX (1) | MXPA05000974A (es) |
| NO (1) | NO20050205L (es) |
| PL (1) | PL212138B1 (es) |
| RU (2) | RU2323941C2 (es) |
| SG (1) | SG177006A1 (es) |
| TW (1) | TWI331922B (es) |
| WO (1) | WO2004014415A1 (es) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI331922B (en) * | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| EP1539959A2 (en) * | 2002-09-18 | 2005-06-15 | Centre Hospitalier de l'Université de Montréal (CHUM) | Ghrh analogues |
| US20040186151A1 (en) * | 2003-02-12 | 2004-09-23 | Mjalli Adnan M.M. | Substituted azole derivatives as therapeutic agents |
| WO2006045314A2 (en) * | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease |
| EP1828243A2 (en) * | 2004-11-30 | 2007-09-05 | Gastrotech Pharma A/S | Growth hormone secretagogue receptor 1a ligands |
| US8138218B2 (en) | 2005-07-22 | 2012-03-20 | Ipsen Pharma S.A.S. | Growth hormone secretagogues |
| RU2566708C2 (ru) * | 2005-09-29 | 2015-10-27 | Ипсен Фарма С.А.С. | Композиции и способы стимуляции двигательной функции желудочно-кишечного тракта |
| EP1818061A1 (en) * | 2005-12-02 | 2007-08-15 | Charite-Universitätsmedizin Berlin | Use of ghrelin for stimulating hair growth |
| CU23592A1 (es) * | 2006-02-28 | 2010-11-11 | Ct Ingenieria Genetica Biotech | Método para prevenir y eliminar las fibrosis y otras formas de depósito patológico en los tejidos aplicando el péptido secretagogo ghrp-6 |
| US20100227806A1 (en) * | 2006-03-10 | 2010-09-09 | Tulipano Giovanni | Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment |
| US8536120B2 (en) * | 2006-04-28 | 2013-09-17 | The Administrators Of The Tulane Educational Fund | Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| CN101541341B (zh) * | 2006-09-27 | 2013-06-05 | 益普生制药两合公司 | N末端取代的生长素释放肽类似物 |
| KR20090119785A (ko) | 2007-03-12 | 2009-11-19 | 유키지루시 뉴교 가부시키가이샤 | 성장 호르몬 분비 촉진제 |
| TW200916113A (en) * | 2007-08-08 | 2009-04-16 | Sod Conseils Rech Applic | Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue |
| WO2009108364A2 (en) * | 2008-02-27 | 2009-09-03 | Ipsen Pharma S.A.S. | Antagonistic analogues of ghrh |
| US9724381B2 (en) | 2009-05-12 | 2017-08-08 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| KR101589191B1 (ko) * | 2010-03-15 | 2016-01-27 | 입센 파마 에스.에이.에스. | 성장 호르몬의 분비를 촉진시키는 수용체 리간드의 약학 조성물 |
| BR112014009418A2 (pt) * | 2011-10-18 | 2017-04-18 | Aileron Therapeutics Inc | macrociclos peptidomiméticos |
| CN104080795A (zh) | 2011-12-23 | 2014-10-01 | 益普生制造爱尔兰有限公司 | 用于合成治疗肽的方法 |
| WO2013119800A1 (en) | 2012-02-07 | 2013-08-15 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| EP2705835A1 (en) * | 2012-06-08 | 2014-03-12 | Ipsen Pharma S.A.S. | Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| CA2978216A1 (en) | 2014-03-04 | 2015-09-11 | Motus Therapeutics, Inc. | Process for the liquid phase synthesis of h-inp-(d)bal-(d)trp-phe-apc-nh2, and pharmaceutically acceptable salts thereof |
| US10317418B2 (en) | 2015-02-24 | 2019-06-11 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| US10111929B1 (en) | 2017-04-07 | 2018-10-30 | Ez Ip, Llc | Growth hormone releasing factor analogs and uses |
| CN113072617B (zh) * | 2021-03-30 | 2023-08-08 | 成都诺和晟泰生物科技有限公司 | 一种多肽化合物及其应用 |
| CN113045625B (zh) * | 2021-03-30 | 2023-11-07 | 成都诺和晟泰生物科技有限公司 | 作为生长激素促分泌素受体激动剂的多肽及其应用 |
| CN114805487B (zh) * | 2022-06-07 | 2024-03-12 | 成都诺和晟泰生物科技有限公司 | 一种多肽化合物及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264565A (en) | 1991-01-22 | 1993-11-23 | Affymax Technologies, N.V. | Nucleic acid encoding the D2 /Ml chimeric receptor |
| JP3131049B2 (ja) * | 1992-09-30 | 2001-01-31 | マツダ株式会社 | 車両のサスペンション装置 |
| PL181280B1 (pl) | 1993-12-23 | 2001-07-31 | Novo Nordisk As | oraz zawierajaca je kompozycja farmaceutyczna PL PL PL PL PL PL PL PL |
| EP0739486A4 (en) * | 1994-01-13 | 1998-09-09 | Univ Columbia | SYNTHETIC RECEPTORS, LIBRARIES AND THEIR USE |
| RU2110275C1 (ru) * | 1994-09-09 | 1998-05-10 | Дейгин Владислав Исакович | Способ получения пептида, обладающего анаболической активностью, стимулирующего увеличение массы тела, развитие эпидермального слоя и роста волосяного покрова |
| ES2186730T3 (es) * | 1994-09-27 | 2003-05-16 | Ardana Bioscience Ltd | Compuestos oligoppeptidicos que contienen un aminoacido d-2-alquiltriptofano y que son capaces de liberar hormona de crecimiento. |
| US20020111461A1 (en) * | 1999-05-21 | 2002-08-15 | Todd C. Somers | Low molecular weight peptidomimetic growth hormone secretagogues |
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
| US5776718A (en) * | 1995-03-24 | 1998-07-07 | Arris Pharmaceutical Corporation | Reversible protease inhibitors |
| CZ287948B6 (cs) | 1995-06-22 | 2001-03-14 | Novo Nordisk A/S | Peptidový derivát uvolňující růstový hormon, farmaceutický prostředek s jeho obsahem a jejich použití |
| CA2200606A1 (en) | 1995-07-26 | 1997-02-13 | Nps Pharmaceuticals, Inc. | Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| US5932548A (en) * | 1998-06-03 | 1999-08-03 | Deghenghi; Romano | Lysine containing peptides for treatment of heart disease |
| US6124263A (en) * | 1998-11-16 | 2000-09-26 | Asta Medica Ag | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| EP1159292A2 (en) | 1998-08-14 | 2001-12-05 | Administrators of The Tulane Educational Fund | Compounds having growth hormone releasing activity |
| DK1795598T3 (da) | 1999-07-23 | 2010-02-01 | Kenji Kangawa | Hidtil ukendte peptider |
| CN1443198A (zh) | 2000-07-24 | 2003-09-17 | 阿达纳生物科学有限公司 | Ghrelin拮抗剂 |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| WO2006045314A2 (en) | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease |
| RU2566708C2 (ru) * | 2005-09-29 | 2015-10-27 | Ипсен Фарма С.А.С. | Композиции и способы стимуляции двигательной функции желудочно-кишечного тракта |
| US20100227806A1 (en) * | 2006-03-10 | 2010-09-09 | Tulipano Giovanni | Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment |
| TW200916113A (en) * | 2007-08-08 | 2009-04-16 | Sod Conseils Rech Applic | Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue |
-
2003
- 2003-08-06 TW TW092121571A patent/TWI331922B/zh not_active IP Right Cessation
- 2003-08-08 DE DE60329923T patent/DE60329923D1/de not_active Expired - Lifetime
- 2003-08-08 MX MXPA05000974A patent/MXPA05000974A/es active IP Right Grant
- 2003-08-08 CN CNA2007101279712A patent/CN101108875A/zh active Pending
- 2003-08-08 US US10/484,473 patent/US7456253B2/en not_active Expired - Lifetime
- 2003-08-08 AU AU2003259062A patent/AU2003259062B2/en not_active Ceased
- 2003-08-08 CN CN201210307885.0A patent/CN102850436B/zh not_active Expired - Fee Related
- 2003-08-08 EP EP03785034A patent/EP1542716B1/en not_active Expired - Lifetime
- 2003-08-08 AT AT03785034T patent/ATE447411T1/de active
- 2003-08-08 CN CNA038186810A patent/CN1674927A/zh active Pending
- 2003-08-08 BR BRPI0313273A patent/BRPI0313273B8/pt not_active IP Right Cessation
- 2003-08-08 PL PL373605A patent/PL212138B1/pl unknown
- 2003-08-08 CA CA2494300A patent/CA2494300C/en not_active Expired - Fee Related
- 2003-08-08 WO PCT/US2003/024834 patent/WO2004014415A1/en not_active Ceased
- 2003-08-08 SG SG2007033848A patent/SG177006A1/en unknown
- 2003-08-08 EP EP09171176A patent/EP2130548A3/en not_active Withdrawn
- 2003-08-08 KR KR1020057001094A patent/KR100967572B1/ko not_active Expired - Fee Related
- 2003-08-08 AR ARP030102883A patent/AR040965A1/es active IP Right Grant
- 2003-08-08 JP JP2004527871A patent/JP4365319B2/ja not_active Expired - Fee Related
- 2003-08-08 ES ES03785034T patent/ES2334223T3/es not_active Expired - Lifetime
- 2003-08-08 CZ CZ20041254A patent/CZ20041254A3/cs unknown
- 2003-08-08 RU RU2005106236/04A patent/RU2323941C2/ru active
- 2003-08-08 BR BR122016015852A patent/BR122016015852B8/pt not_active IP Right Cessation
- 2003-08-08 DK DK03785034.4T patent/DK1542716T3/da active
-
2004
- 2004-12-27 IL IL165998A patent/IL165998A/en active IP Right Grant
-
2005
- 2005-01-13 NO NO20050205A patent/NO20050205L/no not_active Application Discontinuation
-
2007
- 2007-12-03 RU RU2007145026/04A patent/RU2007145026A/ru not_active Application Discontinuation
-
2008
- 2008-03-31 AR ARP080101348A patent/AR062801A2/es not_active Application Discontinuation
- 2008-06-09 US US12/157,224 patent/US8377865B2/en not_active Expired - Fee Related
-
2009
- 2009-01-26 JP JP2009014262A patent/JP5025668B2/ja not_active Expired - Fee Related
-
2013
- 2013-01-04 US US13/734,314 patent/US8859729B2/en not_active Expired - Fee Related
-
2014
- 2014-10-09 US US14/510,188 patent/US9409948B2/en not_active Expired - Fee Related
-
2016
- 2016-07-07 US US15/203,956 patent/US20160311855A1/en not_active Abandoned
-
2017
- 2017-08-29 US US15/688,979 patent/US20170362275A1/en not_active Abandoned
-
2019
- 2019-09-25 US US16/581,960 patent/US20200017548A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR062801A2 (es) | Peptidos liberadores de la hormona de crecimiento | |
| ES2579941T3 (es) | Composiciones farmacéuticas de ligandos del receptor de secretagogos de la hormona del crecimiento | |
| ES2663869T3 (es) | Procedimiento para la síntesis de análogos de la grelina | |
| CO6260151A2 (es) | Peptido de cdh3 y agente medicinal que comprende al mismo | |
| SG172290A1 (en) | Dipeptide linked medicinal agents | |
| NZ593190A (en) | Factor viii formulations | |
| MX378013B (es) | Ésteres alquílicos de treprostinil que tienen una longuitud de cadena de c14 a c18,y el uso de los mismos para el tratamiento de la hipertensión pulmonar. | |
| PE20142113A1 (es) | Analogos de glucagon | |
| PT984982E (pt) | Analogos peptidicos de lh-rh suas utilizacoes e composicoes farmaceuticas contendo-os | |
| AR090439A1 (es) | Lipopeptidos antimicrobianos cortos | |
| AR076977A1 (es) | Proteinas precursoras repetitivas autoensambladas | |
| WO2011038066A4 (en) | Novel npr-b agonists | |
| EP2588127A1 (en) | Dipeptide linked medicinal agents | |
| Zhang et al. | Synthesis of human growth hormone-releasing hormone via three-fragment serine/threonine ligation (STL) | |
| AU2018362018A1 (en) | Peptide conjugate CGRP receptor antagonists and methods of preparation and uses thereof | |
| CR7938A (es) | Formulaciones parenterales de peptidos para el tratamiento de lupus eritematoso sistemico | |
| AR049149A1 (es) | Analogos antagonistas de gh-rh | |
| PE20040961A1 (es) | Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel | |
| CN1956994B (zh) | 上皮系细胞增殖促进剂 | |
| ES2651265T3 (es) | Péptidos sintéticos con un efecto analgésico de tipo no narcótico | |
| RU2006111491A (ru) | Новые противоопухолевые соединения | |
| BR112015018283A2 (pt) | Composto peptídico agonista e composição farmacêutica ou veterinária | |
| RU2013102588A (ru) | Новые октапептидные соединения и их терапевтическое применение | |
| KR20120088700A (ko) | 점안제 | |
| AR030222A1 (es) | Peptidos analogos de somatostatina, un procedimiento para su sintesis, composiciones que los comprenden y el uso de los mismos para la manufactura de un medicamento para el tratamiento de cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |